Skip to main content
Erschienen in: Abdominal Radiology 7/2015

01.10.2015

Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase

verfasst von: Giuseppe Mamone, Gianluca Marrone, Settimo Caruso, Vincenzo Carollo, Giovanni Gentile, Francesca Crino’, Mariapina Milazzo, Angelo Luca

Erschienen in: Abdominal Radiology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose: To describe the Gd-BOPTA MRI findings of intrahepatic mass-forming type cholangiocarcinomas (IMCs), with emphasis on the hepatobiliary phase (HBP). Methods: We reviewed retrospectively 29 IMC patients who underwent Gd-BOPTA-MRI between June, 2004 and June, 2014. Images were acquired prior to, and after, administration of 15–20 mL of Gd-BOPTA in the dynamic phase (arterial phase, portal venous phase, and 3–5 min phase), 10–15-min late phase, and 2–3 h HBP phase. Results: In the dynamic phase, 27 (93%) lesions showed a peripheral rim-like enhancement in the arterial and portal venous phases, followed by progressive filling-in on the delayed images. In 14 (56%) cases, a hypointense peripheral rim was identified in the 10–15-min late phase, delineating a target pattern. In the HBP, the cholangiocarcinoma showed a diffuse, mainly central and inhomogeneous enhancement (cloud of enhancement) in 28 (96%) patients; in 23 (79%) cases, there was an association between cloud appearance and a hypointense peripheral rim, showing a target pattern. Conclusions: Gd-BOPTA MRI pattern of IMC on dynamic study is similar to that of conventional extracellular agents, that is peripheral enhancement with progressive and concentric filling of contrast material on delayed phases. At 10–15 min delayed phases, IMC shows often a peripheral hypointense rim consistent with a target appearance. In the HBP, due to progressive central enhancement (cloud) and peripheral hypointense rim, an higher number of tumors show a target appearance; this pattern is not specific and would also be expected to be seen in metastases from adenocarcinoma.
Literatur
1.
3.
Zurück zum Zitat Tanimoto A, Lee JM, Murakami T, et al. (2009) Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 19(Suppl 5):S975–S989CrossRefPubMed Tanimoto A, Lee JM, Murakami T, et al. (2009) Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 19(Suppl 5):S975–S989CrossRefPubMed
4.
Zurück zum Zitat Jeon TY, Kim SH, Lee WJ, Lim HK (2010) The value of gadobenatedimeglumine–enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 35:337–345CrossRefPubMed Jeon TY, Kim SH, Lee WJ, Lim HK (2010) The value of gadobenatedimeglumine–enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma. Abdom Imaging 35:337–345CrossRefPubMed
5.
Zurück zum Zitat Kim YK, Lee JM, Kim CS (2004) Gadobenatedimeglumine–enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13CrossRefPubMed Kim YK, Lee JM, Kim CS (2004) Gadobenatedimeglumine–enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14:5–13CrossRefPubMed
6.
Zurück zum Zitat Gabata T, Matusi O, Kadoya M, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23:309–313CrossRefPubMed Gabata T, Matusi O, Kadoya M, et al. (1998) Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 23:309–313CrossRefPubMed
7.
Zurück zum Zitat Grazioli L, Bondioni MP, Faccioli N, et al. (2010) Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenatedimeglumine. J Gastrointest Cancer 41(4):221–232CrossRefPubMed Grazioli L, Bondioni MP, Faccioli N, et al. (2010) Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenatedimeglumine. J Gastrointest Cancer 41(4):221–232CrossRefPubMed
8.
Zurück zum Zitat Hwang HS, Kim SH, Jeon TY, et al. (2009) Hypointense hepatic lesions depicted on gadobenatedimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy. Korean J Radiol 10:294–302PubMedCentralCrossRefPubMed Hwang HS, Kim SH, Jeon TY, et al. (2009) Hypointense hepatic lesions depicted on gadobenatedimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy. Korean J Radiol 10:294–302PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Schneider G, Altmeyer K, Kirchin MA, et al. (2007) Evaluation of a novel time-efficient protocol for gadobenatedimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging. Invest Radiol 42:105–115CrossRefPubMed Schneider G, Altmeyer K, Kirchin MA, et al. (2007) Evaluation of a novel time-efficient protocol for gadobenatedimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging. Invest Radiol 42:105–115CrossRefPubMed
10.
Zurück zum Zitat Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR 158:77–79CrossRefPubMed Hamrick-Turner J, Abbitt PL, Ros PR (1992) Intrahepatic cholangiocarcinoma: MR appearance. AJR 158:77–79CrossRefPubMed
11.
Zurück zum Zitat Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65CrossRefPubMed Vilgrain V, Van Beers BE, Flejou JF, et al. (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65CrossRefPubMed
12.
Zurück zum Zitat Ros PR, Buck JL, Goodman ZD, ViamonteRos AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167:689–693CrossRefPubMed Ros PR, Buck JL, Goodman ZD, ViamonteRos AM, Olmsted WW (1988) Intrahepatic cholangiocarcinoma: radiologic-pathologic correlation. Radiology 167:689–693CrossRefPubMed
13.
Zurück zum Zitat Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR 176:1499–1507CrossRefPubMed Maetani Y, Itoh K, Watanabe C, et al. (2001) MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR 176:1499–1507CrossRefPubMed
14.
Zurück zum Zitat Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepaticcholangiocarcinoma with marked hypervascularity. Abdom Imaging 24:66–68CrossRefPubMed Yoshida Y, Imai Y, Murakami T, et al. (1999) Intrahepaticcholangiocarcinoma with marked hypervascularity. Abdom Imaging 24:66–68CrossRefPubMed
15.
Zurück zum Zitat Yoshikawa J, Matsui O, Kadoya M, et al. (1992) Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr 16(2):206–211CrossRefPubMed Yoshikawa J, Matsui O, Kadoya M, et al. (1992) Delayed enhancement of fibrotic areas in hepatic masses: CT-pathologic correlation. J Comput Assist Tomogr 16(2):206–211CrossRefPubMed
16.
Zurück zum Zitat Kim SH, Lee CH, Kim BH, et al. (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyldiethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36(6):704–709CrossRefPubMed Kim SH, Lee CH, Kim BH, et al. (2012) Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyldiethylenetriaminepentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 36(6):704–709CrossRefPubMed
17.
Zurück zum Zitat Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M (1999) The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of “scirrhous-type” and “nonscirrhous-type” growth. Am J Surg Pathol 23:892–902CrossRefPubMed Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M (1999) The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of “scirrhous-type” and “nonscirrhous-type” growth. Am J Surg Pathol 23:892–902CrossRefPubMed
18.
Zurück zum Zitat Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP (1997) Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203(1):98–104CrossRefPubMed Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP (1997) Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 203(1):98–104CrossRefPubMed
19.
Zurück zum Zitat Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium enhanced MR images of focal liver lesions. Radiology 190:49–52CrossRefPubMed Mahfouz AE, Hamm B, Wolf KJ (1994) Peripheral washout: a sign of malignancy on dynamic gadolinium enhanced MR images of focal liver lesions. Radiology 190:49–52CrossRefPubMed
20.
Zurück zum Zitat Jeong HT, Kim MJ, Chung YE, et al. (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201(4):W603–W611CrossRefPubMed Jeong HT, Kim MJ, Chung YE, et al. (2013) Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol 201(4):W603–W611CrossRefPubMed
21.
Zurück zum Zitat Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264(3):751–760CrossRefPubMed Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264(3):751–760CrossRefPubMed
22.
Zurück zum Zitat Worawattanakul S, Semelka RC, Noone TC, et al. (1998) Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 16(9):993–1003CrossRefPubMed Worawattanakul S, Semelka RC, Noone TC, et al. (1998) Cholangiocarcinoma: spectrum of appearances on MR images using current techniques. Magn Reson Imaging 16(9):993–1003CrossRefPubMed
23.
Zurück zum Zitat Schlund JF, Semelka RC, Kettritz U, et al. (1996) Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI. Abdom Imaging 21:49–52CrossRefPubMed Schlund JF, Semelka RC, Kettritz U, et al. (1996) Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI. Abdom Imaging 21:49–52CrossRefPubMed
24.
Zurück zum Zitat Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR 162:1119–1122CrossRefPubMed Soyer P, Bluemke DA, Vissuzaine C, et al. (1994) CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR 162:1119–1122CrossRefPubMed
Metadaten
Titel
Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase
verfasst von
Giuseppe Mamone
Gianluca Marrone
Settimo Caruso
Vincenzo Carollo
Giovanni Gentile
Francesca Crino’
Mariapina Milazzo
Angelo Luca
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 7/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0445-5

Weitere Artikel der Ausgabe 7/2015

Abdominal Radiology 7/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.